IASLC PRESS ROOM - 2013

May

• Media registration opens for World Conference on Lung Cancer (May 16, 2013) 

April

 

• Lung cancer mortality rates linked to primary care provider density (April 22, 2013) 
• Latest research shows careful selection of patients and aggressive intracranial pressure control key to decrease symptoms and prolong survival for patients (April 22, 2013)
• Tumors with ALK rearrangements can harbor more mutations (April 22, 2013) 
• Leading health care organizations issue guideline recommendations for molecular testing and targeted therapies (April 3, 2013) 
• Application process open for Advocacy Travel Awards (April 2, 2013)

March

• Many doctors do not provide tobacco cessation assistance to lung cancer patients (March 28, 2013) 
• Pathologists identify patterns of mutations to help inform design of future trials (March 22, 2013)

February

• Local therapy followed by treatment with EGFR TKI is well tolerated (Feb. 22, 2013) 
• Greater representation of elderly patients in Phase III trails are needed (Feb. 22, 2013) 

January

• EGFR mutation not prognostic factor in non-small cell lung cancer (Jan. 15, 2013) 
• Patients with EGFR exon 20 insertions have poorer prognosis (Jan. 15, 2013) 
• Comparable patterns of failure between SBRT, Lobectomy or pneumonectomy for stage I non-small cell lung cancer (Jan. 15, 2013)

2012 

December

• IASLC names Dr. Alex Adjei JTO Editor-in-Chief (Dec., 2012) 
• Study shows COPD is not independent risk factor for lung cancer (Dec. 15, 2012) 
• Study shows immunohistochemistry is reliable screening tool for ALK rearrangement (Dec. 15, 2012) 
• Study confirms prognostic value of new IASLC/ATS/ERS adenocarinoma sub-classification (Dec. 15, 2012) 

November

 

• Study suggests different approach after progression in NSCLC patients (Nov. 15, 2012) 
• Study shows bone metastases treatment can improve overall survival (Nov. 15, 2012) 
• Study shows large-scale genomic testing feasible, impacts therapy (Nov. 15, 2012) 

• Lung Cancer Awareness Month (Nov. 1, 2012)

October

 

• Study shows fit elderly patients should be considered for therapy (Oct. 15, 2012)
• Study shows revisions in MPM staging system might be needed in future (Oct. 15, 2012) 
• Study says VeriStrat predicts response but not survival benefit from erlotinib (Oct. 15, 2012) 

September

• Study shows breath analysis could help diagnose pulmonary nodules (Sept. 15, 2012) 
• Marital Status, race increase survival rate significantly for stage III non-small cell lung cancer (Sept. 6, 2012)
• Stage I NSCLC patients who receive radiation therapy are surviving longer (Sept. 6, 2012)
• Hispanic/Latino non-small cell lung cancer patients have higher overall survival than non-Hispanic white patients (Sept. 6, 2012)
• Crizontinib reduces tumor size in patients with ALK poitive lung cancer (Sept. 6, 2012)
• Brain radiation after lung cancer treatment reduces risk of cancer spreading (Sept. 6, 2012)
• Standard chemotherapy treatment provides equivalent survival rate than experimental regimen in late-stage lung cancer patients (Sept. 6, 2012)
• Adding bavituximab to second-line chemotherapy doubles response rate in late-stage lung cancer patients (Sept. 6, 2012)

August

• IASLC awarded accreditation as continuing medical education provider (Aug. 25, 2012)

July

• Scientists say details in genetic code critical to treat lung cancer (July 25, 2012)
• Scientists looking for second line of defense for patients with NSCLC (July 25, 2012)
• Lung cancer patient outcomes vary with ethnic background of patients (July 25, 2012)
• Scientists look for non-invasive ways to detect lung cancer early (July 25, 2012)
• Scientists explore molecular link between arsenic exposure and lung cancer (July 25, 2012)
• Researchers find new ways to target therapies for lung cancer patients (July 25, 2012)
• Combination chemotherapy improves survival for NSCLC patients, Brazilian trial (July 19, 2012)
• Patients receiving afatinib in LUX-Lung 3 trial living longer, latest at LALCA2012 (July 19, 2012)
• Study shows positive outcomes with SABR, supports randomized trials (July 19, 2012)
• 5th Latin American Conference on Lung Cancer - Press Conference (July 18, 2012)
• Researchers develop new method for identifying lung nodules (July 15, 2012)

June

• 5th Latin American Conference on Lung Cancer (June 22, 2012)
• Chemotherapy effective for patients with resected small-cell lung cancer or large-cell neuroendocrine carcinoma (June 15, 2012)
• Health-related quality of life study shows stereotactic ablative radiotherapy effective treatment for patients with stage I NSCLC (June 15, 2012)
• Hospital volume and surgeon specialty influence patient outcomes (June 15, 2012)

May

• Video assisted thoracic surgery valuable tool in lung cancer screening (May 15, 2012)
• Chemotherapy's effect on overall survival seems to increase based on tumor size in patients with NSCLC (May 15, 2012)
• A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening (May 15, 2012)

 

April

• Early detection techniques offer hope for improved outcomes in lung cancer patients  (April 18, 2012)
• Advances in personalized medicine in lung cancer (April 18, 2012)
• Gene signature helps identify risk of relapse in lung cancer patients (April 18, 2012)
• Promising developments in early diagnosis and treatment of mesothelioma (April 18, 2012)
• New analysis helps guide use of erlotinib in advanced non-small cell lung cancer (April 18, 2012)
• Urgent research needed to determine most effective follow-up care for lung cancer patients (April 15, 2012)
• Despite obstacles, fine needle aspiration might be best diagnostic tool (April 15, 2012)
• Latest research confirms genetic susceptibility to lung cancer (April 15, 2012)
• Lung cancer drug requires monitoring of testosterone levels (April 5, 2012)

March

• 3rd European Lung Cancer Conference (ELCC) - Media Alert (March 29, 2012)
• Panel of serum biomarkers may reduce number of lung biopsies needed (March 15, 2012)
• CYFRA21-1 might be predictive marker in advanced NSCLC (March 15, 2012)
• Pleurectomy/Decortication proposed preferred surgical procedure (March 15, 2012)

Februrary

• Using online patient communities and new trial approaches to optimize clinical research (Feb. 15, 2012)

January

• The link between TB and a gene mutation that causes lung cancer (Jan. 15, 2012)

• Estrogen-targeting drug combo may help prevent lung cancer (Jan. 10, 2012)

• AACR-IASLC Joint Conference to focus on new diagnostic techniques, potential treatments (Jan. 5, 2012)

2011 

December

• IASLC sets up committee to move CT lung cancer strategic screening forward (Dec. 15, 2011)

September

• Lung cancer ALK rearrangement may predict pemetrexed efficacy, study shows (Sept. 1, 2011)
• Fibrous stroma associated with poor prognosis in lung squamous cell carcinoma (Sept. 1, 2011)

August

• Study: Inexpensive method detects ALK rearrangement in lung cancer patients (Aug. 2, 2011)

July

• Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial (July 4, 2011)
• TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to date (July 4, 2011)
• Lung tumors in never smokers show greater genomic instability than those in smokers (July 4, 2011)
• ALK rearrangement found in nearly 10% of patients in Lung Cancer Mutation Consortium (July 4, 2011)
• EURTAC Phase III study: Erlotinib nearly doubles progression-free survival v. chemotherapy (July 4, 2011)
• High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy (July 4, 2011)
• Endosonography followed by surgical staging improves quality of life, according to ASTER study (July 6, 2011)
• Increased investment in thoracic surgical expertise increased UK lung cancer resection rate (July 6, 2011)
• Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 (July 6, 2011)
• PET scan with [11C] erlotinib may provide non-invasive method to identify TKI-responsive lung tumors (July 6, 2011)
• Cancer patients with blood clots gain no benefit from addition of a vena cava filter to treatment with fondaparinux (July 7, 2011)
• Women, elderly and minorities poorly represented in lung cancer drug trial data submitted to U.S. FDA (July 7, 2011)
• Canada's Cancer Risk Management (CRM) model is an important new health tool for policymakers (July 7, 2011)

June

• IASLC launches Staging Atlas in Thoracic Oncology for iPad, iPhone, Android and BlackBerry (June 1, 2011)
• Five advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam  (June 1, 2011)
• Asian lung cancer patient survival exceeds Caucasians' on multiple regimens (June 10, 2011)

May

• Renal cancer drug temsirolimus shows promise against mesothelioma (May 1, 2011)
• Press program announced for 2011 World Conference on Lung Cancer (May 16, 2011)

April

• New lung cancer staging system (TNM 7) better predicts local/regional recurrence, study shows (April 1, 2011)
• Soy increases radiation's ability to kill lung cancer cells, study shows (April 1, 2011)

March

• Soy increases radiation's ability to kill lung cancer cells, study showsSpontaneous smoking cessation may be an early symptom of lung cancer, research suggests (March 1, 2011)
• Lymph node dissection is not essential in small screen-detected lung cancers, new research shows (March 1, 2011)
• IASLC to help advocacy organizations attend 14th World Conference on Lung Cancer in Amsterdam (March 4, 2011)

February

• High levels of circulating DNA may signal faster progression of lung cancer (Feb. 1, 2011)
• Top lung societies unveil new international classification of lung adenocarcinoma (Feb. 1, 2011)

January

• Study finds evidence of increased lung cancer risk among tuberculosis patients (Jan. 1, 2011)
• Online registration opens for 14th World Conference on Lung Cancer in Amsterdam (Jan. 4, 2011)

 

 2010 

November

• Research explores lung cancer among pediatric cancer patients (Nov. 1, 2010)

October

• TRUST study data confirms safety and efficacy of erlotinib for advanced lung cancer (Oct. 1, 2010)
• New lung cancer research finds half of advanced lung cancer patients receive chemotherapy (Oct. 1, 2010)

September

• Tumor budding identified as predictor for unfavorable outcome in lung cancer (Sept. 1, 2010)
• Lung cancer survival rates improved through use of individualized chemotherapy (Sept. 1, 2010)

August

• Research defines timeframes, factors to deem early stage lung cancer cured (Aug. 2, 2010)
• Lung cancer survivors experience long-term effects of breathlessness (Aug. 2, 2010)

July

• New method of tissue banking makes gene analysis more practical for lung cancer (July 15, 2010)

June

• Novel paclitaxel formulation encouraging for treating advanced lung cancer (June 15, 2010)
• Lung cancer research concludes that early diagnosis is key for improving survival (June 15, 2010)

May

• 2nd European Lung Cancer Conference press program (May 1, 2010)
• Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas (May 5, 2010)

April

• Discover why this is a critical moment for lung cancer research (April 15, 2010)
• Study shows partial lung removal favorable over full removal as treatment for lung cancer (April 1, 2010)

March

• Lung cancer research explores the effects of patient attitudes on patient outcomes (March 3, 2010)
• Patient age not a factor in use of second-line therapy for lung cancer (March 3, 2010)